Xuezhen Ma

Pharmacogenetic (CYP2D6) and gene expression profiles (HOXB13/IL17BR and molecular grade index) for prediction of adjuvant endocrine therapy benefit in the ABCSG 8 trial.

Matthew P. Goetz, Matthew M. Ames, Michael Gnant et al. · Cancer Research · 2009 · 14 citations

Medicine, Oncology, Pharmacology +17

Combined immunotherapy and targeted treatment for primary alveolar soft part sarcoma of the lung: case report and literature review

Hui Su, Chao Yu, Xuezhen Ma et al. · Investigational New Drugs · 2021 · 12 citations

Medicine, Immunology, Oncology +11

Real-World Data on Osimertinib in Chinese Patients with Pretreated, EGFR T790M Mutation Positive, Advanced Non-Small Cell Lung Cancer: A Retrospective Study

Da Peng, Dongfeng Shan, Chengcheng Dai et al. · Cancer Management and Research · 2021 · 12 citations · Full text

Medicine, Oncology, Pharmacology +15

Efficient killing of radioresistant breast cancer cells by cytokine-induced killer cells

Qingming Guo, Danni Zhu, Xiaocui Bu et al. · Tumor Biology · 2017 · 11 citations · Full text

Medicine, Immunology, Oncology +17

Protective Effects of Phytic Acid on CCl4-Induced Liver Fibrosis in Mice

Zhen Xu, Chen Zhao, Tongtong Lan et al. · Journal of Food Biochemistry · 2023 · 11 citations · Full text

Life Sciences, Nutritional Sciences, Pharmacology +17